Caspase inhibitors containing isoxazoline ring
US7557133B2 · kind B2 · utility
0Cited by
0References
21Claims
0Family size
Assignee
Inventors
- Hye Kyung Chang
- Yeong Soo Oh
- Cheol-Won Park
- Yong Jin Jang
- Tae Kyo Park
- Sung Sub Kim
- Min Jung Kim
- Mi Jeong Park
- Jung Gyu PARK
- Hee-Dong Park
- Kyeong-sik Min
- Tae-Soo Lee
- Sang Kyun Lee
- Soo-Hyeon Kim
- Hee-Kyung Jeong
- Sun Hwa Lee
- Hwa-Dong Kim
- Ae Ri Kim
- Ki Sook Park
- Hyun-Ik Shin
- Hyeong Wook Choi
- Kyu-Woong Lee
- Jae-Hoon Lee
- Tae H. Heo
- Ho Jun Kim
- Tae-Sik Kwon
- Jeong Hui Seong
Key dates
| Filing date | Aug 26, 2004 |
| Grant date | Jul 7, 2009 |
| Priority date | — |
| Expiry date | Nov 28, 2025 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02P20/55
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to an isoxazoline derivative as an inhibitor against various caspases, a process for preparing the same, and a therapeutic composition for preventing inflammation and apoptosis comprising the same.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.